Clinical Trials Browser

Phase 2 × Squamous Non-small Cell Lung Cancer × envafolimab × Clear all

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Phase 2 Unknown

Squamous Non-small Cell Lung Cancer